Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Laurus Labs Ltd. ( (IN:LAURUSLABS) ) has provided an announcement.
Laurus Labs Ltd. announced the availability of the audio recording for their Q2 FY26 results conference call, which was held on October 23, 2025. This update is part of their regulatory compliance and transparency efforts, providing stakeholders with access to detailed financial discussions and company performance insights.
More about Laurus Labs Ltd.
Laurus Labs Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs), generic formulations, and biotechnology products. The company is committed to delivering high-quality healthcare solutions and has a significant presence in the global market.
Average Trading Volume: 108,996
Technical Sentiment Signal: Buy
Current Market Cap: 498.7B INR
Find detailed analytics on LAURUSLABS stock on TipRanks’ Stock Analysis page.